EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52023M11260
Prior notification of a concentration (Case M.11260 - APAX PARTNERS / FREMMAN PARTNERS / CHACRIM DIRECTORSHIP) Candidate case for simplified procedure (Text with EEA relevance) 2023/C 320/07
Prior notification of a concentration (Case M.11260 - APAX PARTNERS / FREMMAN PARTNERS / CHACRIM DIRECTORSHIP) Candidate case for simplified procedure (Text with EEA relevance) 2023/C 320/07
Prior notification of a concentration (Case M.11260 - APAX PARTNERS / FREMMAN PARTNERS / CHACRIM DIRECTORSHIP) Candidate case for simplified procedure (Text with EEA relevance) 2023/C 320/07
PUB/2023/1171
OJ C 320, 11.9.2023, p. 9–10
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
11.9.2023 |
EN |
Official Journal of the European Union |
C 320/9 |
Prior notification of a concentration
(Case M.11260 - APAX PARTNERS / FREMMAN PARTNERS / CHACRIM DIRECTORSHIP)
Candidate case for simplified procedure
(Text with EEA relevance)
(2023/C 320/07)
1.
On 1 September 2023, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
|
— |
Apax Partners LLP (‘AP’, UK), |
|
— |
Fremman Partners Limited (‘Fremman’, UK), |
|
— |
Chacrim Directorship, S.L. (the ‘Target’, Spain) controlled by Fremman. |
AP and Fremman will acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of the Target.
The concentration is accomplished by way of purchase of shares.
2.
The business activities of the undertakings concerned are the following:|
— |
AP is a limited liability partnership and the parent of a number of entities which provide investment advisory services to private equity funds investing in a range of industry sectors, |
|
— |
Fremman is a private equity firm active in the investment and management of companies in multiple sectors, |
|
— |
The Target controls a group of companies active in the distribution of medical supplies and devices mainly in Spain (Palex Group), Italy (Gada Group) and Portugal (LusoPalex). |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.
4.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.11260 - APAX PARTNERS / FREMMAN PARTNERS / CHACRIM DIRECTORSHIP
Observations can be sent to the Commission by email or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Postal address:
|
European Commission |
|
Directorate-General for Competition |
|
Merger Registry |
|
1049 Bruxelles/Brussel |
|
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).